Drug Shortage Report for MAR-MONTELUKAST

Last updated on 2025-04-28 History
Report ID 206808
Drug Identification Number 02399997
Brand name MAR-MONTELUKAST
Common or Proper name Montelukast
Company Name MARCAN PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-10-01
Actual start date 2023-10-11
Estimated end date 2024-10-31
Actual end date 2024-11-15
Shortage status Resolved
Updated date 2025-04-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2 GURDWARA RD., SUITE 112
OTTAWA, ONTARIO
CANADA K2E 1A2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-04-28 French Compare
v5 2025-04-28 English Compare
v4 2023-10-12 English Compare
v3 2023-10-11 French Compare
v2 2023-10-11 English Compare
v1 2023-10-11 English Compare

Showing 1 to 6 of 6